[HTML][HTML] SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis

A Rostami, M Sepidarkish, MMG Leeflang… - Clinical Microbiology …, 2021 - Elsevier
global and regional seroprevalence rates in humans of the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV… to estimate the cumulative prevalence of SARS-CoV-2 infection/…

[HTML][HTML] Global seroprevalence of SARS-CoV-2 antibodies: a systematic review and meta-analysis

N Bobrovitz, RK Arora, C Cao, E Boucher, M Liu… - PloS one, 2021 - journals.plos.org
… We conducted a systematic review and meta-analysis of SARS-CoV-2 seroprevalence
studies published in 2020. We aimed to: (i) describe the global prevalence of SARS-CoV-2 …

[PDF][PDF] Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.

SA Meo, AS Meo, FF Al-Jassir… - European Review for …, 2021 - europeanreview.org
global prevalence and the biological and clinical characteristics of the novel Omicron variant
of SARS-CoV-2. … This study recorded the global prevalence and the biological and clinical …

[HTML][HTML] Update on SARS-CoV-2 seroprevalence: regional and worldwide

A Rostami, M Sepidarkish, A Fazlzadeh… - Clinical Microbiology …, 2021 - Elsevier
SARS-CoV-2 virus. Such tests can be used to estimate the cumulative prevalence of SARS-CoV
detailed update on global and regional SARS-CoV-2 seroprevalences around the world. …

[PDF][PDF] Novel coronavirus 2019-nCoV: prevalence, biological and clinical characteristics comparison with SARS-CoV and MERS-CoV.

SA Meo, AM Alhowikan, T Al-Khlaiwi, IM Meo… - European Review for …, 2020 - alatorax.org
… This study aimed at investigating the global prevalence, biological and clinical characteristics
of novel Coronavirus 2019-nCoV, SARS-CoV, and MERS-CoV infection outbreaks. …

[HTML][HTML] The prevalence of symptoms in 24,410 adults infected by the novel coronavirus (SARS-CoV-2; COVID-19): A systematic review and meta-analysis of 148 …

MC Grant, L Geoghegan, M Arbyn, Z Mohammed… - PloS one, 2020 - journals.plos.org
… although the global prevalence of these symptoms remains unclear. The aim of this systematic
review is to determine the prevalence of symptoms associated with COVID-19 worldwide. …

[HTML][HTML] Global prevalence of adaptive and prolonged infections' mutations in the receptor-binding domain of the SARS-CoV-2 spike protein

J Lennerstrand, N Palanisamy - Viruses, 2021 - mdpi.com
… activity, new variants of SARS-CoV-2 are on … SARS-CoV-2 nucleotide sequences on the
NCBI database from the end of 2019 till 28 July 2021, we have estimated the global prevalence

[HTML][HTML] SeroTracker: a global SARS-CoV-2 seroprevalence dashboard

RK Arora, A Joseph, J Van Wyk, S Rocco… - The Lancet Infectious …, 2021 - thelancet.com
… findings from hundreds of global SARS-CoV-2 serological … are reviewed for newly reported
SARS-CoV-2 seroprevalence … Risk of bias for each prevalence estimate is assessed using …

[HTML][HTML] Global prevalence of SARS-CoV-2 3CL protease mutations associated with nirmatrelvir or ensitrelvir resistance

JD Ip, AWH Chu, WM Chan, RCY Leung… - …, 2023 - thelancet.com
… the global prevalence of 3CL pro inhibitor-resistant SARS-CoV-… , and determined their
prevalence among 13.4 million sequences … the prevalence for different time periods, SARS-CoV-2 …

[HTML][HTML] SARS-CoV-2 antibody prevalence in Brazil: results from two successive nationwide serological household surveys

PC Hallal, FP Hartwig, BL Horta, MF Silveira… - The Lancet Global …, 2020 - thelancet.com
… Brazil is currently a hotspot for COVID-19 globally. We aimed to investigate severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody prevalence by city and according …